Evgeny Protasenko

Eugene Protasenko is a tech-savvy finance expert and investor with a focus on early-stage startups in the healthcare and clinical trials sector. He is currently involved with Lindus Health, a UK-based clinical trials startup.1

Professional Background

Eugene Protasenko serves as a Managing Partner at 271, a venture capital firm.2 His expertise lies in creating computational tools that help researchers and businesses leverage data effectively. This background makes him well-suited for investing in innovative healthcare startups like Lindus Health.

Investment Philosophy

Protasenko typically focuses on early-stage investments, but he made an exception for Lindus Health due to the company's significant potential.1 He views the opportunity in the clinical trials space as enormous, which likely influenced his decision to invest in Lindus Health despite it being at a later stage than his usual investments.

Role in Lindus Health

As an investor in Lindus Health, Protasenko is part of a group backing this UK clinical trials startup.1 While he describes his participation as "a small part of this round," his involvement suggests confidence in the company's mission to innovate in the clinical trials sector.1

Personal Traits

Eugene Protasenko is characterized as a tech enthusiast with a passion for leveraging technology in business and research contexts. This aligns well with Lindus Health's focus on modernizing clinical trials through technology.